W O de Steur1, D Henneman1, W H Allum2, J L Dikken3, J W van Sandick4, J Reynolds5, C Mariette6, L Jensen7, J Johansson8, P Kolodziejczyk9, R H Hardwick10, C J H van de Velde11. 1. Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands. 2. Department of Surgery, The Royal Marsden Hospital, London, United Kingdom. 3. Department of Surgery, Medical Center Haaglanden, The Hague, The Netherlands. 4. Department of Surgery, Antoni van Leeuwenhoek Ziekenhuis, Amsterdam, The Netherlands. 5. Department of Surgery, St James's Hospital and Trinity College, Dublin, Ireland. 6. Department of Digestive and Oncological Surgery, University Hospital C Huriez, Lille, France. 7. Department of Surgical Gastroenterology, Aarhus, Denmark. 8. Department of Surgical Oncology, Lund University Hospital, Sweden. 9. Department of Surgery, Jegiellonian University, Krakow, Poland. 10. Cambridge Oesophago-Gastric Centre, Addenbrookes Hospital, Cambridge, United Kingdom. 11. Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands. Electronic address: c.j.h.van_de_velde@lumc.nl.
Abstract
AIMS: Seven countries (Denmark, France, Ireland, the Netherlands, Poland, Sweden, United Kingdom) collaborated to initiate a EURECCA (European Registration of Cancer Care) Upper GI project. The aim of this study was to identify a core dataset of shared items in the different data registries which can be used for future collaboration between countries. METHODS: Item lists from all participating Upper GI cancer registries were collected. Items were scored 'present' when included in the registry, or when the items could be deducted from other items in the registry. The definition of a common item was that it was present in at least six of the seven participating countries. RESULTS: The number of registered items varied between 40 (Poland) and 650 (Ireland). Among the 46 shared items were data on patient characteristics, staging and diagnostics, neoadjuvant treatment, surgery, postoperative course, pathology, and adjuvant treatment. Information on non-surgical treatment was available in only 4 registries. CONCLUSIONS: A list of 46 shared items from seven participating Upper GI cancer registries was created, providing a basis for future quality assurance and research in Upper GI cancer treatment on a European level.
AIMS: Seven countries (Denmark, France, Ireland, the Netherlands, Poland, Sweden, United Kingdom) collaborated to initiate a EURECCA (European Registration of Cancer Care) Upper GI project. The aim of this study was to identify a core dataset of shared items in the different data registries which can be used for future collaboration between countries. METHODS: Item lists from all participating Upper GI cancer registries were collected. Items were scored 'present' when included in the registry, or when the items could be deducted from other items in the registry. The definition of a common item was that it was present in at least six of the seven participating countries. RESULTS: The number of registered items varied between 40 (Poland) and 650 (Ireland). Among the 46 shared items were data on patient characteristics, staging and diagnostics, neoadjuvant treatment, surgery, postoperative course, pathology, and adjuvant treatment. Information on non-surgical treatment was available in only 4 registries. CONCLUSIONS: A list of 46 shared items from seven participating Upper GI cancer registries was created, providing a basis for future quality assurance and research in Upper GI cancer treatment on a European level.
Authors: K E Mulder; S Ahmed; J D Davies; C M Doll; S Dowden; S Gill; V Gordon; P Hebbard; H Lim; A McFadden; J P McGhie; J Park; R Wong Journal: Curr Oncol Date: 2016-12-21 Impact factor: 3.677
Authors: J V Reynolds; S R Preston; B O'Neill; L Baeksgaard; S M Griffin; C Mariette; S Cuffe; M Cunningham; T Crosby; I Parker; K Hofland; G Hanna; L B Svendsen; C L Donohoe; C Muldoon; D O'Toole; C Johnson; N Ravi; G Jones; A K Corkhill; M Illsley; J Mellor; K Lee; M Dib; V Marchesin; M Cunnane; K Scott; P Lawner; S Warren; S O'Reilly; G O'Dowd; G Leonard; B Hennessy; R Mc Dermott Journal: BMC Cancer Date: 2017-06-03 Impact factor: 4.430
Authors: Rishi Mandavia; Alec Knight; John Phillips; Elias Mossialos; Peter Littlejohns; Anne Schilder Journal: BMJ Open Date: 2017-09-24 Impact factor: 2.692
Authors: L A D Busweiler; M Jeremiasen; B P L Wijnhoven; M Lindblad; L Lundell; C J H van de Velde; R A E M Tollenaar; M W J M Wouters; J W van Sandick; J Johansson; J L Dikken Journal: BJS Open Date: 2018-10-19
Authors: Ashika D Maharaj; Jennifer F Holland; Ri O Scarborough; Sue M Evans; Liane J Ioannou; Wendy Brown; Daniel G Croagh; Charles H C Pilgrim; James G Kench; Lara R Lipton; Trevor Leong; John J McNeil; Mehrdad Nikfarjam; Ahmad Aly; Paul R Burton; Paul A Cashin; Julie Chu; Cuong P Duong; Peter Evans; David Goldstein; Andrew Haydon; Michael W Hii; Brett P F Knowles; Neil D Merrett; Michael Michael; Rachel E Neale; Jennifer Philip; Ian W T Porter; Marty Smith; John Spillane; Peter P Tagkalidis; John R Zalcberg Journal: BMJ Open Date: 2019-09-30 Impact factor: 2.692